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bstract
This study sought to investigate the possible mechanisms for the use of phenolic extracts from grapefruit peels in the management/prevention of
ardiovascular complications. The effects of the phenolic extracts on key enzymes relevant to cardiovascular diseases [3-hydroxy-methyl-3-glutaryl
oenzyme A reductase (HMG-CoA reductase) and angiotensin-I converting enzyme (ACE)], cellular antioxidant activity in human endothelial cells
EA.Hy 926) and radicals [1,1-diphenyl-2 picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS)] scavenging
bilities were investigated. The phenolic contents of the extracts were investigated using HPLC–DAD. There was no significant (P  > 0.05) difference
n the HMG-CoA reductase inhibitory ability of the two extracts, while the bound phenolic extracts had a stronger ACE inhibitory ability than
he soluble free phenolics. The extracts also showed intracellular antioxidant activity in human endothelial (EA.Hy 926) cells. Furthermore, the
ound phenolics had significantly higher radicals (DPPH* and ABTS*) scavenging abilities than the free phenolics. The HPLC analysis revealed
he presence of flavonoids (quercetin and kaempferol), phenolics acids (resveratrol, gallic acid, ellagic acid and caffeic acid) and tannin (catechin).
he cellular antioxidative properties and inhibition of enzymes relevant to the management of cardiovascular complications showed that grapefruit
eels could be used as nutraceuticals for the management of such conditions.
 2015 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  Introduction
The link between oxidative stress, endothelial dysfunction
nd cardiovascular diseases (CVDs) has been well established
1]. Clinical studies have shown that there is increased produc-
ion of reactive oxygen species in CVD patients as demonstrated
y clinical studies [2]. The increase in reactive oxygen species
nduces oxidative stress, which then initiates atherosclerosis∗ Corresponding author at: Functional Foods and Nutraceuticals Unit, Depart-
ent of Biochemistry, Federal University of Technology, Akure, Nigeria.
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t the endothelium. Endothelial dysfunction is the first step
n artherosclerosis and a major signal of cardiovascular com-
lications [3]. Lee et al. [4] reported that oxidative stress is
ot only linked to endothelial dysfunction, but to all the pro-
esses involved in atherogenesis up to myocardial infarctions.
urthermore, hypercholesterolemia has been shown to induce
xidative stress [5] thereby causing tissue damage [6]. Low-
ring cholesterol levels has been shown to reduce the risk of
yocardial infarctions and also increased endothelium depend-
nt vasodilation [7]. A vasoconstrictor that has been linked to
ardiovascular complications is angiotensin II, which is pro-
uced by the renin–angiotensin system and has also been linked
o increased oxidative stress [8].
Therefore, the therapeutic targets for the management of
ardiovascular complications include angiotensin-I converting
lsevier B.V. All rights reserved.
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nzyme (catalysing the conversion of angiotensin-I to
ngiotensin-II), 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA)
eductase (catalysing the conversion of HMG-CoA to meval-
nate, which is the rate-limiting step in the synthesis of
holesterol and other isoprenoids) and the use of radical scaven-
ers. The burden of cardiovascular diseases, which is a leading
ause of death and disability in the world [9] is further increased
y the cost of therapy which is beyond the reach of many in
eveloping countries and the search for affordable therapy has
ed to natural alternatives. Grapefruits, like other citrus fruits
ave a smaller edible portion compared to the amount of non-
dible portions such as peels and seeds. However, it has been
hown that there are more bioactive compounds in the peels of
itrus fruits than in the juices [10]. Grapefruit peels are domesti-
ally processed into candies and consumed by some Americans
omes, while the peels are taken as infusion drinks in Asia.
he bioactive compounds present in the peels, especially the
henolic compounds have been shown to have some medicinal
roperties [11]. However, these bioactive compounds in the peels
ave been of little benefit to humans as they are grossly under-
tilized in many countries. This study sought to investigate the
ffect of phenolic extracts from grapefruit peels on key enzymes
elevant to the management of cardiovascular diseases and also
he cellular antioxidant activities of the extracts in endothelial
ells.
.  Materials  and  methods
.1.  Sample  collection  and  preparation
Grapefruits (Citrus  paradisii) were purchased from the Main
arket, Akure, South West, Nigeria [7.2500◦ N, 5.1950◦ E].
he fruits were peeled and the peels were air dried and ground
o fine powder using Warring Commercial heavy Duty Blender
Model 37BL18; 24ØCB6). The water used was glass distilled,
hile the chemicals were of analytical grade.
.2.  Extraction  of  free  soluble  phenolics
The extraction of free soluble phenolics was carried out
ccording to the method reported by Chu et al. [12]. 10 g of
he ground peels was extracted with 80% acetone (1:5, w/v) and
ltered (filter paper Whatman no. 2) under vacuum. The filtrate
as then evaporated using a rotary evaporator under vacuum at
5 ◦C until about 90% of the filtrate had been evaporated. The
henolic extracts were frozen at −40 ◦C, while the residues were
ept for the extraction of bound phenolics.
.3.  Extraction  of  bound  phenolics
The residue from free soluble extraction above was flushed
ith nitrogen and hydrolysed with about 20 mL of 4 M NaOH
olution at room temperature for 1 h with shaking. Then, the
H of the mixture adjusted to pH 2 with concentrated HCl and
he bound phytochemicals were extracted with ethyl acetate
nd repeated five times. The ethyl acetate fractions were then
vaporated at 45 ◦C [12].
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.4.  Cell  cultures
The human endothelial cell line (EA.Hy 926) was purchased
rom the American Type Culture Collection (Rockville, MD,
SA). EA.Hy 926 cells were cultured in complete DMEM
i.e., supplemented with 10% foetal bovine serum, 1 mM
-glutamine, and 1 mM penicillin–streptomycin). Cells were
rown in an incubator at 37 ◦C in a humidified atmosphere (95%
ir and 5% carbon dioxide).
.5.  HMG-CoA  reductase  activity
The commercially available HMG-CoA reductase assay kit
rom Sigma–Aldrich (Steinheim, Germany) was used to screen
he phenolic extracts according to the manufacturer’s instruc-
ions. A 0.2 mL reaction mixture containing 1 L of appropriate
ilutions of the extracts or pravastatin solution (control), 4 L of
econstituted NADPH, 12 L of HMG-CoA solution and 2 L
MG-CoA reductase was vigorously shaken mechanically in
he plate reader for 10 s, and the rates of NADPH consumed
ere monitored every 20 s for 600 s by scanning spectrophoto-
etrically the decrease in absorbance at 340 nm, using Infinite
200 Pro plate reader (Tecan, Männedorf, Switzerland). The
lank experiment did not contain HMG-CoA Reductase or any
f the studied substances. The Area Under Curve (AUC) of the
urves obtained were calculated using GraphPad Prism soft-
are (version 5.00, GraphPad Software, San Diego, USA). The
btained AUC values were divided by the AUC of the control
xperiments (no inhibitors) to obtain the percentage inhibition.
ll results were expressed as a mean ±  SD of three repetitions,
nd IC50, i.e., the half maximal inhibition concentration, were
alculated using GraphPad Prism software.
.6.  Angiotensin  I-converting  enzyme  (ACE)  inhibition
ssay
Appropriate dilution of the phenolic extracts (50 mL) and
CE solution (50 mL, 4 mU) was incubated at 37 ◦C for 15 min.
he enzymatic reaction was initiated by adding 150 mL of
.33 mmol/L of the substrate Bz–Gly–His–Leu in 125 mmol/L
ris–HCl buffer (pH 8.3) to the mixture. After incubation for
0 min at 37 ◦C, the reaction was arrested by adding 250 mL
f 1 mol/L HCl. The Gly–His bond was then cleaved and the
z–Gly produced by the reaction was extracted with 1.5 mL
thyl acetate. Thereafter the mixture was centrifuged to sepa-
ate the ethyl acetate layer; then 1 mL of the ethyl acetate layer
as transferred to a clean test tube and evaporated. The residue
as re-dissolved in distilled water and its absorbance was mea-
ured at 228 nm. The ACE inhibitory activity was expressed as
ercentage inhibition [13].
.7.  Cellular  antioxidant  activity  (CAA)  assay
The intracellular formation of peroxyl radical was detected
y the method of Wolfe and Liu [14]. EA.Hy 926 cells were
eeded at a density of 1 × 104 cells/well on a 96-well microplate
n 100 L of growth medium/well. The outside wells of the
late were not used. Twenty-four hours after seeding, the growth
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could be the possible mechanism for the cholesterol lowering
effect of the peels in experimental animals as observed by pre-
vious studies [18]. Although, as shown in this study the extracts
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edium was removed, the wells were washed with PBS, and the
ells were treated for 1 h with the extracts (0.1 g/L, 1 g/L,
0 g/L, 100 g/L) plus 25 mol/L DCFH-DA dissolved in
reatment medium. After the indicated period, cells were washed
nd 600 mol/L ABAP dissolved in HBSS was added to the
ells. Fluorescence was measured (λex = 485 nm, λem = 538 nm)
very 5 min for 30 min at 37 ◦C on a microplate reader (Plate
hameleon, HIDEX). Each concentration of each substance was
epeated in six wells. Each plate also included six control and six
lank wells: control wells contained cells treated with the dye
DCFH-DA) and the oxidant (ABAP); blank wells contained
ells treated with DCFH-DA and HBSS without the oxidant.
.7.1. Quantiﬁcation  of  CAA
After blank subtraction from fluorescence readings, the area
nder the curve of fluorescence versus time was integrated to cal-
ulate the CAA value at each concentration of extract as follows:
AA unit = (∫ SA/ ∫ CA) ×  100, where ∫ SA is the integrated
rea under the sample fluorescence versus time curve and
∫
CA
s the integrated area from the control curve [14].
.8.  DPPH  free  radical  scavenging  ability
The free radical scavenging ability of the extracts against
PPH (1,1-diphenyl-2 picrylhydrazyl) free radical was eval-
ated as described by Gyamfi et al. [15]. Briefly, appropriate
ilution of the extracts (1 mL) was mixed with 1 mL, 0.4 mmol/L
ethanolic solution containing DPPH radicals, the mixture was
eft in the dark for 30 min and the absorbance was taken at
16 nm. The DPPH free radical scavenging ability was subse-
uently calculated.
.9.  2,2′-Azino-bis(3-ethylbenzthiazoline-6-sulphonic  acid)
ABTS)  radical  scavenging  ability
The ABTS* scavenging ability of the essential oil was deter-
ined according to the method described by Re et al. [16]. The
BTS* was generated by the reaction of an (7 mmol/L) ABTS
queous solution with K2S2O8 (2.45 mmol/L, final concentra-
ion) in the dark for 16 h and adjusting the Abs 734 nm to 0.700
ith ethanol. Samples of 0.2 mL of the extract were added to
.0 mL ABTS* solution and the absorbance was measured at
34 nm after 15 min. Trolox was used as a reference compound.
he results were expressed as Trolox equivalent antioxidant
apacity (TEAC) values.
.10.  Quantiﬁcation  of  compounds  by  HPLC–DAD
Reverse phase chromatographic analyses were car-
ied out under gradient conditions using C18 column
4.6 mm ×  150 mm) packed with 5 m diameter particles; the
obile phase was water containing 2% acetic acid (A) and
ethanol (B), and the composition gradient was: 5% (B) for min; 25% (B) until 10 min; 40, 50%, 60%, 70% and 80%
B) every 10 min; following the method described by Freitas
t al. [17] with slight modifications. The phenolic extracts
ere filtered through 0.45 m membrane filter (Millipore)
F
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nd then degassed by ultrasonic bath prior to use. The flow
ate was 0.7 mL/min, injection volume 50 L and the wave-
ength was 254 nm for gallic acid and resveratrol, 280 nm
or catechin and epicatechin, 327 nm for caffeic and ellagic
cids, and 366 nm for quercetin, rutin and kaempferol. The
amples and mobile phase were filtered through 0.45 m
embrane filter (Millipore) and then degassed by ultrasonic
ath prior to use. Stock solutions of standards references were
repared in the HPLC mobile phase at a concentration range
f 0.010–0.100 mg/mL for resveratrol, catechin, epicatechin,
uercetin, rutin and kaempferol; and 0.050–0.200 mg/mL for
allic, ellagic and caffeic acids. The chromatography peaks
ere confirmed by comparing its retention time with those
f reference standards and by DAD spectra (200–600 nm).
alibration curve for gallic acid was: Y = 13,057x  + 1254.9
r = 0.9993); catechin: Y  = 12,724x  + 1258.0 (r  = 0.9997); epi-
atechin: Y  = 11,973x  + 1317.8 (r = 0.9999); resveratrol: Y  =
1,983x  + 1306.5 (r  = 0.9993); caffeic acid: Y  = 11,872x  +
570.3 (r  = 0.9996); ellagic acid: Y  = 12,728x  + 1367.4 (r  =
.9998); quercetin: Y  = 13,149x  + 1267.8 (r  = 0.9999); rutin: Y  =
2,657x + 1340.5 (r  = 0.9996) and kaempferol: Y  = 15,983x  +
321.5 (r  = 0.9992). All chromatography operations were
arried out at ambient temperature and in triplicate.
.  Results  and  discussion
The dose-dependent inhibition of HMG-CoA reductase activ-
ty by the extracts as presented in Fig. 1 and the IC50 values in
able 1 showed that there was no significant (P  > 0.05) difference
n the inhibitory abilities of the two extracts. The control of ele-
ated cholesterol levels has become imperative in recent times
s hypercholesterolemia has been established as a risk factor for
therosclerosis and other cardiovascular complications. In most
ases, the reduction of cholesterol synthesis is achieved by inhi-
ition of HMG-CoA reductase, which is the rate limiting enzyme
n cholesterol synthesis. Therefore, the inhibition of HMG-CoA
eductase by the phenolic extracts from grapefruit peels would be
eneficial in the management of cardiovascular complications.
he HMG-CoA reductase inhibition by the phenolic extractsConcentration of extracts (µg/L) 
ig. 1. Inhibition of 3-hydroxy-methyl-3-glutaryl coenzyme A reductase
HMG-CoA reductase) activity by grapefruit peels’ phenolic extracts.
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Table 1
Antioxidant capacity and IC50 values.
Free Bound
Trolox equivalent antioxidant
capacity (mmol/g)
5.72 ± 0.11b 6.87 ± 0.09a
IC50 values
HMG-CoA reductase
(g/L)
114.99 ± 7.14a 115.31 ± 8.21a
ACE (g/L) 169.09 ± 9.16b 137.40 ± 8.41a
DPPH* (g/L) 209.03 ± 5.68b 178.95 ± 4.93a
Trolox equivalent antioxidant capacity, IC50 values for the 3-hydroxy-methyl-
3-glutaryl coenzyme A reductase (HMG-CoA reductase), and angiotensin-I
converting enzyme (ACE) inhibition and 1,1-diphenyl-2 picrylhydrazyl (DPPH)
radicals scavenging abilities of free and bound phenolic extracts of grapefruit
peels.
Values represent mean ± standard deviation of triplicate readings.
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avourably compared with pravastatin in inhibiting the HMG-
oA reductase especially at higher concentrations, it should be
oted that phenolic compounds, especially flavonoids are not
tructurally similar to statins.
Statins inhibit HMG-CoA reductase activity by competing
ith HMG-CoA for the enzyme active site [19]. The competi-
ive inhibition of pravastatin is made possible by its structural
imilarity to HMG-CoA by the possession of a double cyclic
ing structure [20]. However, in the case of phenolic compounds,
avonoids such as genistein and diadzein have been shown to
nhibit HMG-CoA reductase activity both competitively with
MG-CoA and non-competitively with NADPH [21]. While
tatins are widely used in the management of cardiovascular
omplications [22], recent studies have supported the use of
MG-CoA reductase inhibitors from natural sources due to the
ide effects of statins [23].
Furthermore, the extracts inhibited ACE activity in a dose-
ependent manner (Fig. 2) with the bound phenolics having
 stronger inhibitory ability than the soluble free phenolics.
nother mechanism for the management of cardiovascular com-
lications such as hypertension is the use of ACE inhibitors.
CE inhibition prevents the enzyme from catalysing the conver-
ion of angiotensin I to the powerful vasoconstrictor, angiotensin
I [24]. Phenolic-rich extracts from natural products have been
hown from previous studies to inhibit ACE activity [11,25,26].
he HPLC analysis of the extracts revealed the presence of
0
20
40
60
80
100
0 50 10 0 15 0 20 0 250
Con centration  of ex tracts (µg/L)
%
 A
CE
 in
hi
bi
tio
n
Grapefruit-free Grapefruit-bound
ig. 2. Inhibition of angiotensin-I converting enzyme (ACE) activity by grape-
ruit peels’ phenolic extracts.
o
t
(
a
r
D
f
A
i
t
p
i
o
e
oig. 3. 1,1-Diphenyl-2 picrylhydrazyl (DPPH) radical scavenging ability of
rapefruit peels’ phenolic extracts.
aempferol, rutin and quercetin which have been shown from
revious studies to be ACE inhibitors [27]. Angiotensin II does
ot only stimulate vasoconstriction, but also oxidative stress.
ngiotensin II-induced oxidative stress has been shown to play
 major role in the development of hypertension [28,29].
More so, the role of angiotensin II-induced reactive oxy-
en species (ROS) formation in atherogenesis has been well
stablished [30]. It is also noteworthy that the anti-oxidative
ffects of ACE inhibitors contribute to their therapeutic effects
n patients suffering from cardiovascular complications [31].
lso, hypercholesterolemia has been shown to induce oxidative
tress in experimental animals [5]. Generally, oxidative stress
as been implicated in the development of major cardiovascular
onditions such as atherosclerosis, ischaemic heart disease and
ypertension [2]. Therefore, the antioxidative effects of pheno-
ic compounds might also contribute to the medicinal effects of
rapefruit peels in the management of cardiovascular complica-
ions.
The anti-oxidative effects of the phenolic extracts from the
rapefruit peels was tested in endothelial cells EA.Hy 926 and
lso in cell free system using DPPH and ABTS assays. The
ose-dependent DPPH* scavenging ability (Fig. 3) revealed
hat the bound phenolics had significantly higher scavenging
bility than the free phenolics. Table 1 showed that the bound
henolics had significantly higher ABTS* scavenging ability
han the free soluble phenolic extracts. Fig. 4 showed the time
ourses for peroxyl radical-induced oxidation of DCFH to DCF
n human endothelial cells (EA.Hy 926) cells and the inhibition
f oxidation by grapefruit peel phenolic extracts. Fig. 5 showed
hat the CAA units for the extracts at the concentrations tested
0.1–100 g/L) were 6.5–31.42% and 8.88–46.42% for the free
nd bound phenolics respectively.
These results showed that the phenolic extracts scavenged the
adicals and prevented the oxidation of the membrane lipids and
CFH, thereby reducing the formation of DCF. DCF is formed
rom the reaction between DCFH trapped in the cells and the
BAP-induced peroxyl radicals. The cellular antioxidant activ-
ty (CAA) of the phenolic extracts in EA.Hy 926 cells showed
hat the phenolic extracts were able to exhibit anti-oxidative
roperties in physiological conditions. The CAA of the extracts
n endothelial cells is also therapeutically important as reactive
xygen species are produced at all layers of the vascular wall,
specially at the endothelium [31]. Therefore, the prevention of
xidative stress-induced endothelial dysfunction has become a
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Fig. 6. Representative high performance liquid chromatography profile of [A]
grapefruit free phenolic extracts and [B] bound phenolic extracts. Detection UV
was at 327 nm. Gallic acid (peak 1), catechin (peak 2), resveratrol (peak 3),
caffeic acid (peak 4), ellagic acid (peak 5), epicatechin (peak 6), rutin (peak 7),
quercetin (peak 8) and kaempferol (peak 9).
Table 2
Phenolic composition of grapefruit (free and bound) extract.
Compounds Free, mg/g Bound Peak, mg/g
Gallic acid 10.19 ± 0.02a 9.85 ± 0.03a 1
Catechin 4.98 ± 0.01b 4.21 ± 0.02b 2
Resveratrol 22.56 ± 0.02c 19.36 ± 0.01c 3
Caffeic acid 23.72 ± 0.01c 23.65 ± 0.01d 4
Ellagic acid 11.24 ± 0.03a 18.91 ± 0.02c 5
Epicatechin 7.83 ± 0.01d 4.97 ± 0.01b 6
Rutin 8.16 ± 0.02d 4.35 ± 0.03b 7
Quercetin 15.29 ± 0.01e 9.83 ± 0.02a 8
Kaempferol 10.45 ± 0.01a 4.30 ± 0.01b 9
Results are expressed as mean ± standard deviations (n = 3).
V
dA.Hy 926 cells and the inhibition of oxidation by grapefruit peels’ [A] free
nd [B] bound phenolic extracts.
ajor therapeutic target in the management of cardiovascular
omplications [32,33].
Clinical trials have shown that the use of HMG-CoA reduc-
ase inhibitors in patients at coronary risk improved endothelial
unction through reduction of oxidative stress and/or up reg-
lation of NO activity [34]. Furthermore, some studies have
hown the synergistic effect of the use of HMG-CoA reductase
nhibitors and ACE inhibitors in reducing inflammatory mark-
rs in atherosclerotic rabbits [35]. Therefore, the anti-oxidative
roperties of the phenolic extracts from the peels, combined
ith their inhibition of HMG-CoA reductase and ACE could be
seful in the management/prevention of oxidative stress-induced
ndothelial dysfunction mediated cardiovascular complications.
HPLC fingerprinting of grapefruit peels (free and bound)
evealed the presence of gallic acid (tR = 11.87 min; peak 1),
atechin (tR = 15.69 min; peak 2), resveratrol (tR = 20.03 min;
eak 3), caffeic acid (tR = 23.91; peak 4), ellagic acid
tR = 28.17 min; peak 5), epicatechin (tR = 34.29 min; peak 6),
utin (tR = 42.67 min; peak 7), quercetin (tR = 47.21 min; peak
) and kaempferol (tR = 51.26 min; peak 9) (Fig. 6 and Table 2).
lthough the bound phenolic extracts had lower concentrations
f most of the phenolic compounds identified, it had higher
ig. 5. Dose–response curves for inhibition/increase of peroxyl radical-induced
CFH oxidation grapefruit peels phenolic extracts.
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aalues with the same superscript letter on the same column are not significantly
ifferent (P > 0.05).
ioactivity than the free phenolic extracts in the assays used
n this study. It could be speculated that the method of extrac-
ion for the bound phenolics makes a wider variety of phenolic
ompounds available which might not have been identified by
he finger-printing [36].
.  Conclusion
The inhibition of HMG-CoA reductase and ACE activities, as
ell as the anti-oxidative abilities of the phenolic extracts from
rapefruit peels in endothelial cells could be part of the mecha-
ism by which the peels manage and/or prevent cardiovascular
iseases. However, further in vivo experiments and clinical trials
re recommended.
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